The Analysis of Immuno-Nutrition Index in Advanced Gastric Cancer Receiving Preoperative Treatments

Peking University

Status: Enrolling

Conditions: Gastric Cancer; Systemic Inflammatory Response Syndrome (SIRS); Neoadjuvant Chemoradiotherapy; Neoadjuvant Chemotherapy; Nutrition Aspect of Cancer

Study type: Observational

Funder types: Other

Identifiers

NCT03493880

INdex

Details and patient eligibility

About

Based on multiple studies, the immune (systemic inflammation) and nutrition index were correlated with short- and long-term prognosis for gastric cancer. With the increasing application of preoperative treatments (chemotherapy and chemoradiotherapy), the issues concerning how are the immuno-nutrition index be altered under the effects of perioperative treatments and what are the clinical values of these index should be clarified.

Full description

The immune (systemic inflammation) index includes:

NLR (Neutrophil-to-Lymphocyte Ratio); PLR (Platelet-to-Lymphocyte Ratio); SII (Systemic Immune-Inflammation Index); GPS (Glasgow Prognostic Score); mGPS (modified Glasgow Prognostic Score); PI (Prognostic Index);

The nutrition index includes:

NRS2002; PNI (Prognostic Nutrition Index);

Enrollment: 600 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Histologically confirmed adenocarcinoma
• Received neoadjuvant (preoperative) chemotherapy or chemoradiotherapy
• Diagnosed clinical advanced gastric cancer or esophagogastric cancer

Exclusion criteria

• Lack of immuno-nutrition data

Trial design

600 participants in 2 patient groups

naCT

Description:

Advanced gastric cancer or esophagogastric cancer receiving neoadjuvant (preoperative) chemotherapy.

naCRT

Description:

Advanced gastric cancer or esophagogastric cancer receiving neoadjuvant (preoperative) chemoradiotherapy.